Just over two years ago, the FDA granted orphan drug status to rofecoxib for the treatment of hemophilic arthropathy. Rofecoxib was previously marketed by Merck under the trade name of Vioxx and depending on your age, you may recall hearing about Vioxx in the news. Vioxx was initially approved by the FDA in 1999 for […] Continue
The Centers for Medicare & Medicaid Services issued an alert today that it will be hosting two town hall meetings to discuss common Commercial Repayment Center (CRC) Non-Group Health Plan (NGHP) Ongoing Responsibility for Medicals (ORM) and Group Health Plan (GHP) recovery topics. The first town hall will be held on January 14, 2020 at 1:00 […] Continue
In recent years, a great deal of attention has been paid to the topic of drug prices and more specifically, how to control them. On a personal note, it’s likely that most of us have gone to the pharmacy to pick up a prescription and been surprised by the cost. On a professional note, in […] Continue
The Medicare Secondary Payer (MSP) provisions of the Social Security Act prohibit Medicare from making payment where payment has been made or can reasonably be expected to be made by a primary plan. If payment has not been made, or cannot reasonably be expected to be made promptly by the plan, Medicare may pay for […] Continue
Earlier this month, in a press release, the United States Attorney for the District of Maryland Robert K. Hur announced that a Baltimore-based law firm has paid the United States $91,406.98 to resolve allegations that it failed to reimburse Medicare for conditional payments that had been made to medical providers on behalf of firm clients. […] Continue